NASDAQ:BLFS

BioLife Solutions (BLFS) Stock Price, News & Analysis

BioLife Solutions logo
$38.61 0.00 (0.00%)
As of 11/6/2026

About BioLife Solutions Stock (NASDAQ:BLFS)

Advanced

Key Stats

Today's Range
$38.61
▼
$38.61
50-Day Range
$34.92
▼
$39.22
52-Week Range
$17.86
▼
$39.76
Volume
N/A
Average Volume
1.18 million shs
Market Capitalization
$1.89 billion
P/E Ratio
33.28
Dividend Yield
N/A
Price Target
$31.38
Consensus Rating
Hold

Company Overview

BioLife Solutions, Inc. develops and supplies products and services used in the development and commercial production of cell and gene therapies and other biologic medicines. Its offerings support the handling, preservation, storage and distribution of sensitive biological materials.

The company’s products include CryoStor and HypoThermosol preservation media, as well as CellSeal bags designed for cryogenic storage. BioLife also provides temperature-controlled storage and repository services for biological materials through its SciSafe business.

BioLife has expanded beyond its roots in biopreservation products to offer a broader portfolio for biopharmaceutical and life sciences customers. It serves customers in the United States and internationally, including therapy developers, biopharmaceutical companies and research organizations.

AI Generated. May Contain Errors.

BioLife Solutions Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
26th Percentile Overall Score

BLFS MarketRank™: 
1.31991814461 of 5 stars

BioLife Solutions scored higher than 26% of companies evaluated by MarketBeat, and ranked 1485th out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    BioLife Solutions has received a consensus rating of Hold. The company's average rating score is 2.09, and is based on no strong buy ratings, 1 buy rating, 10 hold ratings, and no sell ratings.

  • Downside Risk

    BioLife Solutions has a consensus price target of $31.38, representing about 18.7% downside from its current price of $38.61.

  • Amount of Analyst Coverage

    BioLife Solutions has only been the subject of 2 research reports in the past 90 days.

  • Read more about BioLife Solutions' stock forecast and price target.
  • Earnings Growth

    Earnings for BioLife Solutions are expected to grow by 433.33% in the coming year, from $0.03 to $0.16 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of BioLife Solutions is 33.28, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.70.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of BioLife Solutions is 33.28, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.83.

  • Price to Book Value per Share Ratio

    BioLife Solutions has a P/B Ratio of 5.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for BLFS.
  • Dividend Yield

    BioLife Solutions does not currently pay a dividend.

  • Dividend Growth

    BioLife Solutions does not have a long track record of dividend growth.

  • News Sentiment

    BioLife Solutions has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for BioLife Solutions this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, BioLife Solutions insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.20% of the stock of BioLife Solutions is held by insiders.

  • Percentage Held by Institutions

    93.24% of the stock of BioLife Solutions is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about BioLife Solutions' insider trading history.
Receive BLFS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioLife Solutions and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BLFS Stock News Headlines

My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel
BioLife Solutions, Inc.(NasdaqCM:BLFS) dropped from S&P 1000
Repligen Closes BioLife Solutions Acquisition
See More Headlines

BLFS Stock Analysis - Frequently Asked Questions

BioLife Solutions' stock was trading at $24.18 at the beginning of the year. Since then, BLFS shares have increased by 59.7% and is now trading at $38.61.

BioLife Solutions, Inc. (NASDAQ:BLFS) released its quarterly earnings data on Thursday, August, 6th. The medical equipment provider reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.88. The medical equipment provider earned $28.47 million during the quarter, compared to analyst estimates of $27.80 million. BioLife Solutions had a trailing twelve-month return on equity of 2.70% and a net margin of 53.29%.

BioLife Solutions' top institutional investors include Glazer Capital LLC (8.35%), Goldman Sachs Group Inc. (3.72%), State Street Corp (3.38%) and First Trust Capital Management L.P. (2.91%). Insiders that own company stock include Casdin Partners Master Fund, L, Aby J Mathew, Greef Roderick De, Troy Wichterman, Todd Berard, Garrie Richardson, Karen A Foster, Sarah Aebersold, Geraint Phillips, Sean Werner, Joydeep Goswami and Amy Duross.
View institutional ownership trends
.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioLife Solutions investors own include Micron Technology (MU), Alibaba Group (BABA), Block (XYZ), NVIDIA (NVDA), Advanced Micro Devices (AMD), Gilead Sciences (GILD) and Intel (INTC).

Company Calendar

Last Earnings
8/06/2026
Today
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:BLFS
CIK
834365
Employees
440
Year Founded
1987

Price Target and Rating

High Price Target
$34.00
Low Price Target
$31.00
Potential Upside/Downside
-18.7%
Consensus Rating
Hold
Rating Score (0-4)
2.09
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.16
Trailing P/E Ratio
33.28
Forward P/E Ratio
241.31
P/E Growth
N/A
Net Income
-$4.59 million
Net Margins
53.29%
Pretax Margin
6.28%
Return on Equity
2.70%
Return on Assets
2.49%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.69
Quick Ratio
7.14

Sales & Book Value

Annual Sales
$106.69 million
Price / Sales
17.71
Cash Flow
$0.23 per share
Price / Cash Flow
168.62
Book Value
$7.72 per share
Price / Book
5.00

Miscellaneous

Outstanding Shares
48,923,000
Free Float
47,847,000
Market Cap
$1.89 billion
Optionable
Optionable
Beta
1.82

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

This page (NASDAQ:BLFS) was last updated on 11/6/2026 by MarketBeat.com Staff.
From Our Partners